Results 261 to 270 of about 717,412 (277)
Some of the next articles are maybe not open access.
Current Medical Research and Opinion, 2003
Managing invasive fungal infections often presents a challenge for clinicians in the treatment of immunocompromised patients. Two very different systemic antifungal agents, voriconazole and caspofungin, have recently been introduced into the market place. Voriconazole is a new triazole antifungal, while caspofungin is the first echinocandin antifungal.
openaire +2 more sources
Managing invasive fungal infections often presents a challenge for clinicians in the treatment of immunocompromised patients. Two very different systemic antifungal agents, voriconazole and caspofungin, have recently been introduced into the market place. Voriconazole is a new triazole antifungal, while caspofungin is the first echinocandin antifungal.
openaire +2 more sources
Cellular and Molecular Life Sciences, 2014
Fungal disease is an increasing problem in both agriculture and human health. Treatment of human fungal disease involves the use of chemical fungicides, which generally target the integrity of the fungal plasma membrane or cell wall. Chemical fungicides used for the treatment of plant disease, have more diverse mechanisms of action including inhibition
Brigitte M E, Hayes +4 more
openaire +2 more sources
Fungal disease is an increasing problem in both agriculture and human health. Treatment of human fungal disease involves the use of chemical fungicides, which generally target the integrity of the fungal plasma membrane or cell wall. Chemical fungicides used for the treatment of plant disease, have more diverse mechanisms of action including inhibition
Brigitte M E, Hayes +4 more
openaire +2 more sources
Leukemia Research
Voriconazole has been a standard antifungal prophylactic (AFP) agent for patients with acute myeloid leukemia (AML) during neutropenia. However, its use is complicated by side-effects including transaminase elevations, visual disturbances, and significant drug-drug interactions (DDIs).
Cameron J. Hunter +9 more
openaire +2 more sources
Voriconazole has been a standard antifungal prophylactic (AFP) agent for patients with acute myeloid leukemia (AML) during neutropenia. However, its use is complicated by side-effects including transaminase elevations, visual disturbances, and significant drug-drug interactions (DDIs).
Cameron J. Hunter +9 more
openaire +2 more sources
Evolution of antifungal drug tolerance in Candida albicans
2019Mestrado em Biomedicina ...
openaire +1 more source
Identification and Elimination of Antifungal Tolerance in Candida auris
Biomedicines, 2023Daniel A. Charlebois +2 more
exaly
Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans.
MBio, 2021Hui Lu, Feng Yang, Judith Berman
exaly
Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology
Journal of Fungi (Basel, Switzerland), 2023Arianna Tavanti +2 more
exaly
Drug resistance and tolerance in fungi
Nature Reviews Microbiology, 2020Damian Krysan, Judith Berman
exaly